Immediate Impact

2 by Nobel laureates 6 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
A systems view of the vascular endothelium in health and disease
2024 Standout
19 intermediate papers

Works of Jill Fredrickson being referenced

Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
2018
A phase Ib dose-escalation study of the safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of the humanized monoclonal antibody (huMAb) anti-EGFL7 (MEGF0444A) in combination with bevacizumab with or without paclitaxel in patients with advanced solid tumors.
2011
and 4 more

Author Peers

Author Last Decade Papers Cites
Jill Fredrickson 382 330 338 32 1.2k
Yanling Wang 208 315 368 56 1.0k
Stefan Vöö 341 208 492 45 1.1k
Min Ren 305 320 319 75 1.6k
Vineet K. Raghu 238 162 230 40 1.0k
Siân Griffin 154 447 304 46 1.6k
Julie Lee 234 258 240 42 1.2k
Yasuo Ejima 175 328 386 49 1.3k
Hao Zhang 243 609 512 77 1.4k
Kazuhiro Miwa 560 348 358 57 1.6k
Barbara Corti 410 197 812 68 1.5k

All Works

Loading papers...

Rankless by CCL
2026